Loading stock data…
$8.11-0.81 (-9.08%)
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.
Senseonics Holdings, Inc. in the Healthcare sector is trading at $8.11 with a market capitalization of $509M. Wall Street consensus targets $13.67 (6 analysts), implying a +68.5% move over the next 12 months. The stock is currently 24% below its 52-week high of $10.64, remaining 14.4% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 24 is oversold, raising the odds of a near-term bounce. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $14.48M↑ | $11.71M↓ | $14.26M↑ | $8.10M↑ | $6.65M |
| Gross Profit | $8.56M↑ | $6.94M↓ | $7.67M↑ | $3.47M↑ | $3.12M |
| Operating Income | -$35.99M↓ | -$31.85M↓ | -$20.93M↓ | -$19.60M↓ | -$14.32M |
| Net Income | -$36.70M↓ | -$32.33M↓ | -$20.82M↓ | -$19.53M↓ | -$14.50M |
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include ...